What are the top competitors of Medacta Group S.A. in Healthcare sector?

The top competitors of Medacta Group S.A. in the Healthcare sector are: Abbott Laboratories (ABT.SW), Zimmer Biomet Holdings, Inc. (ZBH.SW), Sonova Holding AG (SOON.SW), Medartis Holding AG (MED.SW).

Which has better valuations & earnings, Medacta Group S.A. or its competitors?

Medacta Group S.A. has a market cap of 3.1B and a Dividend Yield of 0.45% compared to its competitors.

Which stock is more profitable: Medacta Group S.A. or its competitors?

Medacta Group S.A. has an EPS of CHF4.40, while ABT.SW has an EPS of CHF2.95. So, Medacta Group S.A. is more profitable compared to ABT.SW.

What is Medacta Group S.A. stock volatility and risk in terms of investment?

Medacta Group S.A. has daily volatility of 2.5% as compared to its competitor ABT.SW which is 1.76%. Medacta Group S.A. is more volatile as compared to competitors and has high risk.

Is Medacta Group S.A. stock profitable?

Medacta Group S.A. has a Return on Equity (ROE) of 0.22%. So, Medacta Group S.A. is more profitable.

What is Medacta Group S.A. stock’s 52 weeks high and low?

Medacta Group S.A. stock has a 52-week high of (CHF177.2) and a low of (CHF104.6).

What was the average volume of Medacta Group S.A. stock?

The average volume of Medacta Group S.A. is (17.7K) in terms of investment.

Medacta Group S.A. (MOVE.SW) Competitors

Medacta Group S.A. (MOVE.SW) Stock Competitors & Peer Comparison

See (MOVE.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
MOVE.SW	CHF 153.80	-0.26%	3.1B	34.95	CHF 4.40	+0.45%
ABT.SW	CHF 84.50	-3.98%	146.8B	28.64	CHF 2.95	+2.29%
ZBH.SW	CHF 67.50	-4.26%	13.2B	24.19	CHF 2.79	+1.13%
SOON.SW	CHF 179.75	+0.50%	10.7B	20.64	CHF 8.71	+2.45%
MED.SW	CHF 81.60	+1.49%	1B	121.79	CHF 0.67	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MOVE.SW vs ABT.SW Comparison April 2026

MOVE.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MOVE.SW stands at 3.1B. In comparison, ABT.SW has a market cap of 146.8B. Regarding current trading prices, MOVE.SW is priced at CHF 153.80, while ABT.SW trades at CHF 84.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MOVE.SW currently has a P/E ratio of 34.95, whereas ABT.SW's P/E ratio is 28.64. In terms of profitability, MOVE.SW's ROE is +0.22%, compared to ABT.SW's ROE of +0.13%. Regarding short-term risk, MOVE.SW is more volatile compared to ABT.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MOVE.SW.Check ABT.SW's competition here

Medacta Group S.A.